Please login to the form below
antimicrobial
This page shows the latest antimicrobial news and features for those working in and with pharma, biotech and healthcare.
UK launches subscription-style payment pilot to incentivise pharma antibiotics R&D
The UK government has taken a lead among nations in addressing the growing dangers of ‘superbugs’ and antimicrobial resistance (AMR) with the need for new classes of antimicrobials one of the ... which raised 1.5m in March for its proprietary
Latest news
-
Non-antibiotic could ‘transform pneumonia therapy’
It has been estimated that antimicrobial resistance (AMR) could lead to 10m extra deaths a year and cost the global economy up to £75 trillion by 2050 unless new ways to
-
UK biotech bags €1.5m grant for new antibiotic class
Procarta will use the new money to develop a pipeline of an entirely new class of antibiotic precision medicines from Procarta’s proprietary oligonucleotide-based antimicrobial platform, and is one of ... growing antimicrobial resistance,” said
-
Bicycle Therapeutics to tackle AMR with government funding
Biotech to discover new class of antibacterial agents. UK biotech company Bicycle Therapeutics is to develop a new class of antibacterial agents to tackle antimicrobial resistance (AMR) after receiving a grant ... Lee adds: “The Department of Health
-
European Medicines Agency departs London ahead of Brexit
That list includes public health issues including the availability of medicines – for example by tackling the threat of drug shortages – and antimicrobial resistance (AMR), as well as ensuring “timely access to
-
UK unveils new antibiotic buying plan, pharma incentives
Health minister compares upfront payment model to Spotify. Health Secretary Matt Hancock has revealed the UK’s next five-year plan to handle the rising threat of antimicrobial resistance (AMR), estimated ... Key elements of the five-year strategy
More from news
Approximately 40 fully matching, plus 64 partially matching documents found.
Latest Intelligence
-
25 Women Leaders in UK Healthcare
dementia and antimicrobials. ... It is focusing on four areas of acute medical and societal need where it believes healthcare comms can play a big role: antimicrobial resistance, mental health, obesity and precision medicine.
-
Combining therapies and combining research
Antimicrobial resistance (AMR) is a complex issue of global concern that has the potential to void advances in modern medicine. ... There are growing concerns about the lack of new drug development surrounding antimicrobial resistance.
-
Rules of engagement
Fewer than half of the nearly 10, 000 respondents had heard of the term ‘antimicrobial resistance’.
-
No incentive for a cure
The stakes are too high for this not to happen. The risk we face from antimicrobial resistance and the current lack of new antibiotics tells us all we need to know
-
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge. A look at some of the headline statistics on the antimicrobial resistance (AMR) issue is particularly sobering. ... market. About the AMR Centre. The AMR Centre is a key part of the UK’s response to the
More from intelligence
Approximately 6 fully matching, plus 8 partially matching documents found.
Latest appointments
-
IFPMA names new communications director
and to enable government to meet ambitious goals such as universal health coverage, global health security and continued innovation in areas of high unmet health needs such as antimicrobial resistance.
-
Destiny Pharma appoints new CEO
Destiny Pharma has appointed Neil Clark as CEO as the Brighton, UK-based firm plans a phase IIb trial for its lead antimicrobial candidate.
-
New health ministers and re-appointments after reshuffle
Ellison, who reprises her role as the secretary for public health that she has held since 2013, also has a wide remit that includes pharma as will have responsibility for: antimicrobial
-
Xellia forms scientific advisory board
drugs to help tackle the global crisis of antimicrobial resistance.”. ... Antimicrobial resistance is a huge area of unmet medical need and one of the greatest threats to human health.
-
Cubist picks Robert Perez as its new CEO
area as the world recognises the growing threat of antimicrobial resistance.
More from appointments
Approximately 1 fully matching, plus 5 partially matching documents found.
Latest from PMHub
-
Mobilising the public to combat the antimicrobial resistance crisis
Antimicrobial resistance is one of the greatest threats to human health, according to the World Health Organisation. ... Her illness is due to antimicrobial resistance (AMR) and it is not as rare as you might think.
-
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians navigating ... Antimicrobial resistance claims 5,
-
Antibiotic Resistance: Alarm bells ring louder than ever
where antibiotics and the threat of antimicrobial resistance (AMR) became a hot topic in the mainstream media. ... Another angle is the development of small molecules that can be administered in conjunction with antimicrobials to prevent resistance
-
Cello Health
Though international focus is turning to antimicrobial resistance and incentives are being provided for research into new drugs, there are many hurdles to be jumped before a blockbuster can be discovered
-
Blue Latitude Health
Antimicrobial resistance is one of the greatest threats to human health, according to the World Health Organisation. ... Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial
More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.
Featured jobs
- FREELANCE Account Director – Healthcare Advertising – London – 3...
-
Competitive Daily Rates
- FREELANCE Medical Writer (Initial 2/ 3 months term) - London Off...
-
Excellent Daily Rate
- Account Director – London based Medical Communications Agency
-
Excellent Remuneration Package
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Account Director - Medical Communications - London / South East
-
Excellent Salary and Benefits on offer
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
-
Account Director – UK Office
-
Excellent salary and benefits
- Account Director, Healthcare Communications
-
Salary TBC
Subscribe to our email news alerts
- GSK hires Merck KGaA exec to lead US pharma business
- Novartis chooses internal replacement for US pharma president role
- Moving annual total (MAT)
- Roche undercuts price of Bayer cancer drug after winning FDA approval
- Novartis chooses internal replacement for US pharma president role
- Lilly psoriasis drug beats J&J's Tremfya in head-to-head trial
- Lilly’s Levi Garraway will replace Sandra Horning as Roche CMO
- Blended Intelligence
- Planning a pharma exhibition stand? You must read this!
- Leaked no-deal Brexit document forecasts widespread shortages
- AbbVie scores FDA approval for arthritis treatment upadacitinib
- Novo Nordisk shareholder revolt reaches Europe
PMHub
Novasecta
We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...
Latest intelligence
- Blended Intelligence
- Data is the most valued commodity of the modern world. For P&P it's all about the application....
- The relevance of patient perspectives to value
- Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
- How is the NHS Long-term Plan being put into action?
- Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
Quick links
Infographics
